Specific Epstein-Barr virus serological response in patients with nasopharyngeal carcinoma detected by immunoblotting.
The specific humoral immune response against Epstein-Barr virus (EBV) antigens in patients with nasopharyngeal carcinoma (NPC) was compared to that of patients with infectious mononucleosis (IM) and other EBV-seropositive subjects using immunoblotting technique. Almost all sera from EBV serologically associated NPC reacted reproducibly with a major group of polypeptides (four to six) of early antigen (EA) complex with molecular weights ranging from 50 kD to 58 kD, and with some additional polypeptides. Sera from IM-patients reproducibly recognized only one polypeptide of 50 kD belonging to the major group of polypeptides of EA-complex. Sera from patients with other types of head and neck cancer and relatively high levels of IgG antibody against viral capsid antigen (VCA) and EA did not react reproducibly with any of the EBV-associated proteins.
Cevenini
R
R
Istituto di Microbiologia, Università di Bologna, Italy.
Donati
M
M
Moroni
A
A
Caliceti
U
U
Rinaldi-Ceroni
A
A
La Placa
M
M
D002277:Carcinoma / Q000276:immunology*; D002294:Carcinoma, Squamous Cell / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D015151:Immunoblotting; D007244:Infectious Mononucleosis / Q000276:immunology; D009303:Nasopharyngeal Neoplasms / Q000276:immunology*